REGN Filings — Regeneron Pharmaceuticals, Inc.

FilingSpy

REGN Filings — Regeneron Pharmaceuticals, Inc. - FilingSpy

Insiders trading · 6M

1 selling · 0 buying

Bought · 6M

—

0 open-market buys

Sold · 6M

300

34 open-market sales

Own-timing sales

of 300 sold

Insiders

Ranked by how much each holding moved in the last 6 months

Larosa Joseph JEVP General Counsel and Secret · 2 transactions

45.6K+7.8%

Granted 12.3K

Fenimore Christopher R.EVP Finance CFO · 2 transactions

23.5K+7.8%

Granted 6.3K

Ryan Arthur FDirector · 34 transactions

17.6K-1.7%

Sold 300

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Larosa Joseph JEVP General Counsel and Secret · 2 transactions	+7.8%	45.6K	12.3K	—	—
Fenimore Christopher R.EVP Finance CFO · 2 transactions	+7.8%	23.5K	6.3K	—	—
Ryan Arthur FDirector · 34 transactions	-1.7%	17.6K	—	—	300

Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.

Net open-market activity over the last 6 months: -300 shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.